Julianne Hough is the new face of…
Julianne Hough is the new face of Revance’s Botox rival [...]
Julianne Hough is the new face of Revance’s Botox rival [...]
Incyte has dropped its lawsuit in exchange for the CMS [...]
As a sweltering heat wave hit Europe, a swath of [...]
The Claudin18.2-targeted therapy is the first CAR-T to win global [...]
Amid efforts in Germany to retool the country’s drug spending, [...]
Before Aurobindo can complete its acquisition of Pennsylvania generics specialist [...]
Pfizer’s CFO Dave Denton will officially depart in August, leaving [...]
With interest in automated cell therapy production beginning to build [...]
Name recognition and “familiarity” with Novo Nordisk’s oral Wegovy has [...]
Four years after Spero Therapeutics received a complete response letter [...]